Serum Institute of India NeuClone / NeuClone Pty Ltd / /
Continent
Europe / /
Country
Taiwan / Japan / United States / Canada / Australia / United Kingdom / South Korea / New Zealand / / /
Event
Business Partnership / /
Facility
Serum Institute of India / Serum Institute / /
IndustryTerm
based on core technologies / immense biologics manufacturing capability / production culture media / vaccine producer / biotechnology / expression technologies / pharmaceutical industry / manufacturing infrastructure / manufacturing advantages / platform technology / biologics manufacturing plant / biosimilar products / manufacturing / drug products / /
Organization
Serum Institute / NeuClone and Serum Institute / Australian Technology Park National Innovation Centre / Serum Institute of India / Australian Government / FDA / /
Person
Noelle Sunstrom / / /
Position
Chief Executive Officer / Major / Start Leader in cell line development / vaccine producer / /
Product
NeuMAXTM platform / NeuMAXTM / /
Region
Scandinavia / /
Technology
expression technologies / platform technology / biotechnology / drug development / /
Who we are NeuClone’s Partnering Strategy Sydney-based biotechnology company NeuClone is a private biotechnology business, started in 2007